Epidemiology of pediatric chronic kidney disease/kidney failure: learning from registries and cohort studies

Ryoko Harada(Tokyo Metropolitan Children's Medical Center), Kenji Ishikura(Kitasato University), Riku Hamada, Yuko Hamasaki(Toho University), Yusuke Okuda(Kitasato University)

Pediatric Nephrology

June 6, 2021

10.1007/s00467-021-05145-1

Cited by 149

Related Papers

Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial

|The Lancet|2014|450

IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome

|Pediatric Nephrology|2022|278

Creatinine-based equation to estimate the glomerular filtration rate in Japanese children and adolescents with chronic kidney disease

|Clinical and Experimental Nephrology|2013|267

A multicenter randomized trial indicates initial prednisolone treatment for childhood nephrotic syndrome for two months is not inferior to six-month treatment

|Kidney International|2014|135

ERK and p38 mediate high-glucose-induced hypertrophy and TGF-β expression in renal tubular cells

|American Journal of Physiology-Renal Physiology|2004|126